[由于多发性硬化症的自我注射药物导致的尼科劳综合征]
Revista de neurologia
|July 19, 2023
概括
尼古拉氏综合征是一种罕见的皮肤并发症,发生在多发性硬化症患者中,这些患者使用了glatiramer acetate (GA) 自给注射. 这种在男性中更常见的情况可能会复发,影响治疗决策.
科学领域:
- 皮肤病学 皮肤病学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 尼古拉氏综合征 (embolia cutis medicamentosa) 是药物注射后的一种罕见不良事件.
- 它与多发性硬化症 (MS) 药物一起发生的情况很少被记录.
研究的目的:
- 研究多发性硬化症患者中尼古拉综合征的发病率和特征,这些患者接受了自我注射药物治疗.
- 分析尼古拉症候群与特定的MS疗法之间的关联.
主要方法:
- 从2010年1月到2022年10月进行了一项回顾性研究.
- 患者数据包括那些接受多发性硬化症自我注射β干扰素和glatiramer乙酸 (GA) 的患者.
- 记录和分析了尼古拉症候群的发生率.
主要成果:
- 在接受glatiramer acetate (GA) 的7名患者 (6名男性,1名女性) 中观察到10次尼古拉氏综合征发作.
- 这占GA患者的5.3%,部和手臂是受影响最严重的区域.
- 在42.8%的受影响患者中,发现尼古拉综合征的复发.
结论:
- 在这种多发性硬化症队列中,尼古拉综合征似乎是一种与格拉蒂拉默酸盐 (GA) 特别相关的并发症.
- 这种综合症在男性患者中更为普遍,并且显示出明显的复发率.
- 这些发现需要仔细考虑正在进行的GA治疗与替代治疗策略.
相关概念视频
Drugs Acting on Autonomic Ganglia: Stimulants
1.4K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.4K
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Drug Delivery: Miscellaneous Routes
384
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
384
Drug Delivery: Parenteral Route
627
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
627
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K


